Cardiovascular dysfunction in children conceived by assisted reproductive technologies.

Scherrer, Urs; Rexhaj, Emrush; Allemann, Yves; Sartori, Claudio; Rimoldi, Stefano (2015). Cardiovascular dysfunction in children conceived by assisted reproductive technologies. European Heart Journal, 36(25), pp. 1583-1589. Oxford University Press 10.1093/eurheartj/ehv145

[img]
Preview
Text
1583.full.pdf - Published Version
Available under License Publisher holds Copyright.

Download (344kB) | Preview

Epidemiological studies demonstrate a relationship between pathological events during foetal development and future cardiovascular risk and the term 'foetal programming of cardiovascular disease' has been coined to describe this phenomenon. The use of assisted reproductive technologies (ARTs) is growing exponentially and 2-5% of children are now born by this procedure. Emerging evidence indicates that ART represents a novel important example of foetal programming. Assisted reproductive technology may modify the cardiovascular phenotype in two ways: (i) ART involves manipulation of the early embryo which is exquisitely sensitive to environmental insults. In line with this concern, ART alters vascular and cardiac function in children and studies in mice show that ART alters the cardiovascular phenotype by epigenetic alterations related to suboptimal culture conditions. (ii) Assisted reproductive technology markedly increases the risk of foetal insults that augment cardiovascular risk in naturally conceived individuals and are expected to have similar consequences in the ART population. Given the young age of the ART population, it will take another 20-30 years before data on cardiovascular endpoints will be available. What is clear already, however, is that ART emerges as an important cardiovascular risk factor. This insight requires us to revise notions on ART's long-term safety and to engage on a debate on its future. There is an urgent need to better understand the mechanisms underpinning ART-induced alteration of the cardiovascular phenotype, improve the procedure and its long-term safety, and, while awaiting this aim, not to abandon medicine's fundamental principle of doing no harm (to future children) and use ART parsimoniously.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Scherrer, Urs, Rexhaj, Emrush, Allemann, Yves, Rimoldi, Stefano

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

0195-668X

Publisher:

Oxford University Press

Language:

English

Submitter:

Stefano Rimoldi

Date Deposited:

11 May 2016 16:40

Last Modified:

05 Dec 2022 14:52

Publisher DOI:

10.1093/eurheartj/ehv145

PubMed ID:

25911649

Uncontrolled Keywords:

Arterial hypertension; Endothelium; Epigenetic; In vitro fertilization; Pulmonary hypertension; eNOS

BORIS DOI:

10.7892/boris.76413

URI:

https://boris.unibe.ch/id/eprint/76413

Actions (login required)

Edit item Edit item
Provide Feedback